SCHEMBL6950366

SCHEMBL6950366

CC(=O)NC1(c2ccccc2)CCN(CCC(CN2C(=O)c3ccccc3C2=O)c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 5/20 0.67
TACR1 P25103 3/20 0.67
TACR3 P29371 8/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089179 0.86 TACR2 (0.75) TACR2TACR1TACR3
SCHEMBL7870009 0.86 TACR2 (0.73) TACR2TACR1TACR3
SCHEMBL6952599 0.86 TACR2 (0.73) TACR2TACR1TACR3
SCHEMBL6588311 0.82 TACR2 (0.69) TACR2TACR1TACR3
SCHEMBL7870048 0.81 TACR2 (0.67) TACR2TACR1TACR3
SCHEMBL6033897 0.81 TACR2 (0.64) TACR2TACR1TACR3
SCHEMBL6160860 0.80 TACR2 (0.62) TACR2TACR1TACR3
SCHEMBL7312636 0.80 TACR2 (0.66) TACR2TACR1TACR3
SCHEMBL8482847 0.80 TACR2 (0.66) TACR2TACR1TACR3
Saredutant SCHEMBL185911 0.80 TACR2 (1.00) TACR2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709376-B1 Phenylpiperidino derivatives as neurokinin antagonists ASTRAZENECA AB (SE) 2003-07-23 EP disclosed
US-6573381-B1 Useful as intermediates, notably for the synthesis of methyl (S)-2(2-chlorophenyl)-2(4,5,6,7-tetrahydrothieno(3,2-c)-5-pyridyl)acetate or clopidrogel SANOFI-SYNTHELABO (FR) 2003-06-03 US disclosed
US-6008223-A ANTIINFLAMMATORY AGENTS FOR TREATING ASTHMA ZENECA LIMITED (GB) 1999-12-28 US disclosed
US-5731309-A Substituted heteroalkyleneamine neurokinin antagonists ZENECA LIMITED (GB) 1998-03-24 US disclosed
EP-0709376-A2 Therapeutic compounds ZENECA LIMITED (GB) 1996-05-01 EP disclosed